0000899243-20-023658.txt : 20200831 0000899243-20-023658.hdr.sgml : 20200831 20200831095917 ACCESSION NUMBER: 0000899243-20-023658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200827 FILED AS OF DATE: 20200831 DATE AS OF CHANGE: 20200831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARK PAUL N CENTRAL INDEX KEY: 0001222248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 201150096 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD STREET 2: MS 1A-LC CITY: SANTA CLARA STATE: CA ZIP: 95051 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-27 0 0001098972 AGENUS INC AGEN 0001222248 CLARK PAUL N C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to buy) 4.03 2020-08-27 4 A 0 100000 0.00 A 2030-08-27 Common Stock 100000 100000 D Restricted Stock Unit 2020-08-27 4 A 0 11786 0.00 A 2021-08-27 Common Stock 11786 11786 D Stock Option awarded in connection with Mr. Clark's appointment to the Board of Directors (the "Board") in accordance with the Agenus Inc. 2019 Equity Incentive Plan (the "2019 Plan") and non-employee director compensation program. Stock option vests in three equal annual installments on each of August 27, 2021, 2022 and 2023 (provided Mr. Clark maintains a service relationship with the company through each such vesting date). Restricted Stock Unit granted in connection with Mr. Clark's appointment to the Executive Committee of the Board in accordance with the 2019 Plan. The award vests in full on August 27, 2021 (provided Mr. Clark maintains a service relationship with the company through each such vesting date). /s/ Evan D. Kearns, as Attorney-in-Fact for Paul N. Clark 2020-08-31